4//SEC Filing
Wijkstrom Joakim 4
Accession 0001209191-21-014882
CIK 0001347178other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:19 PM ET
Size
7.7 KB
Accession
0001209191-21-014882
Insider Transaction Report
Form 4
Wijkstrom Joakim
SVP, Chief Marketing Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-02-24+61,200→ 61,200 totalExercise: $20.28Exp: 2031-02-23→ Common Stock (61,200 underlying) - Award
Common Stock
2021-02-24+25,800→ 82,090 total
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F2]The option vests with respect to 25% of the underlying shares on February 24, 2022, with the balance vesting in equal monthly installments over the next 36 months of continuous service thereafter, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001785888
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:19 PM ET
- Size
- 7.7 KB